Originally published In Press as doi:10.1074/jbc.M200550200 on March 27, 2002
J. Biol. Chem., Vol. 277, Issue 24, 21269-21277, June 14, 2002
Ku Is Important for Telomere Maintenance, but Not for
Differential Expression of Telomeric VSG Genes, in African
Trypanosomes*
Colin
Conway,
Richard
McCulloch
,
Michael L.
Ginger§,
Nicholas
P.
Robinson,
Alison
Browitt, and
J. David
Barry¶
From the Wellcome Centre for Molecular Parasitology, University of
Glasgow, Anderson College, 56 Dumbarton Road, Glasgow, G11
6NU, Scotland, United Kingdom
Received for publication, January 17, 2002, and in revised form, March 25, 2002
 |
ABSTRACT |
Trypanosome antigenic variation, involving
differential expression of variant surface glycoprotein (VSG) genes,
has a strong association with telomeres and with DNA recombination. All
expressed VSGs are telomeric, and differential activation
involves recombination into the telomeric environment or
silencing/activation of subtelomeric promoters. A number of pathogen
contingency gene systems associated with immune evasion involve
telomeric loci, which has prompted speculation that chromosome ends
provide conditions conducive for the operation of rapid gene switching
mechanisms. Ku is a protein associated with eukaryotic telomeres that
is directly involved in DNA recombination and in gene silencing. We
have tested the hypothesis that Ku in trypanosomes is centrally
involved in differential VSG expression. We show, via the
generation of null mutants, that trypanosome Ku is closely involved in
telomere length maintenance, more so for a transcriptionally active
than an inactive telomere, but exhibits no detectable influence on DNA
double strand break repair. The absence of Ku and the consequent great
shortening of telomeres had no detectable influence either on the rate
of VSG switching or on the silencing of the telomeric promoters of the
VSG subset that is expressed in the tsetse fly.
 |
INTRODUCTION |
The heterodimeric protein Ku, which consists of the subunits Ku70
and Ku80 (or Ku86), associates tightly in a sequence-independent fashion with free ends of double strand DNA and has been associated with a range of nuclear functions in different eukaryotes (reviewed in
Refs. 1-3), including DNA repair, retrotransposition (4), gene
silencing, transcriptional reinitiation (5), chromosome maintenance,
and chromosome localization. Recently, homologues possibly associated
with DNA repair have been discovered also in prokaryotes (6, 7). Ku is
central to the non-homologous end joining
(NHEJ)1 pathway for
DNA double strand break repair in which double strand breaks with
dissimilar ends can be rejoined with minimal error (8). A main function
of Ku is to bind to DNA and recruit proteins, such as the catalytic
subunit of mammalian DNA-dependent protein kinase, that
catalyze steps in the repair process, although a weak helicase activity
has been ascribed by some to Ku itself (1). Ku also plays a major role
in telomere length maintenance in yeasts such that the deletion of Ku
genes causes shortening of the telomere tract (9-11). This function of
Ku again is thought to operate mainly through its interaction with
other molecules (12, 13). The NHEJ function of Ku is prevented from
acting at telomeres by other telosome proteins such as Taz1 (14), and indeed the presence of Ku is required for the prevention of
recombination at the free ends of telomeres (15, 16).
In the phenomenon known as telomere position effect (TPE),
telomere-proximal genes in yeast become transcriptionally silent in a
reversible manner (17). The deletion of KU genes in
Saccharomyces cerevisiae prevents the silencing (18),
although the removal of Ku from Schizosaccharomyces pombe
does not have this effect (11). Although TPE has been demonstrated
where reporter genes have been inserted experimentally into telomeres
(17, 19), there is only one example of it occurring naturally. A screen of telomere-proximal genes on a number of S. cerevisiae
chromosomes revealed that, although generally they are not subject to
TPE, one does appear to be silenced in that way (20).
Pathogenic microorganisms commonly use contingency gene systems that,
by undergoing random and rapid mutational events, create phenotypic
diversity during infection and can enable evasion of host immune
systems (21-23). Contingency genes often are members of large gene
families of which only one is expressed at a time, and the mutational
events can include a random switch between expression of individual
members of the family. It is common for contingency genes, including
the one that is expressed, to be located at telomeres (24-26). Just
why telomeres are so popular for such genes is unknown, but it has been
speculated that the high rates of recombination between telomeres
contribute to diversification within the family. It has also been
proposed that telomeric location is more directly involved in phenotype
switching by using effects such as TPE to enable transcriptional
switching between members of the family (25, 27-29). The sleeping
sickness parasite Trypanosoma brucei has a variant surface
glycoprotein (VSG) protective coat that undergoes extensive antigenic
variation during evasion of host immunity (reviewed in Refs. 23, 24,
and 30-32). When antibodies kill trypanosomes expressing a specific
VSG, a minority of cells that have switched to expression of a distinct
VSG survive and multiply. Each trypanosome has a family of probably
hundreds of VSG genes, most of which are located in tandem
arrays within chromosomes, but a sizeable minority of which are located
at the many telomeres in this genome. To obtain exclusive expression of
VSGs, trypanosomes transcribe them singly and only at
telomeric sites known as bloodstream expression sites (BESs). Although
there can be occasional transcriptional switches between BESs, the main
route to VSG switching is the replacement of the VSG in the
BES with a copy of a silent VSG (33), probably by homologous
recombination (34). However, it is not known yet whether special,
telomere-associated mechanisms enhance recombination into BESs, and a
role for telomere-associated recombination-promoting proteins is a
possibility. Ku, interacting with proteins other than those preventing
recombination at the free end of the telomere, is a candidate.
It is also possible to invoke Ku, in its role as mediator of TPE, as a
candidate for regulating differential expression and repression of the
distinct set of VSGs employed when the VSG coat first
appears in the metacyclic trypanosome stage in the salivary glands of
the tsetse (Glossina) vector (reviewed in Refs. 29 and 35).
In that stage, a subset of telomeric genes known as MVSGs
becomes differentially activated at the transcriptional level,
generating a population diverse for VSGs. As these are the only
trypanosome protein-coding genes known to have their own promoters, and
to be subject to absolute control by transcription initiation, it has
been speculated that they have achieved such control through the
operation of a TPE on the MVSG promoters, which are
only ~5 kb from the telomere tract (29). Here, we examine the
functions of Ku in trypanosomes and test the hypothesis that it is
important for VSG switching in the bloodstream stage and that it is
also important for the silencing of MVSG genes prior to the
metacyclic stage.
 |
EXPERIMENTAL PROCEDURES |
Trypanosome Strains and Transformation--
Bloodstream form
cells (T. brucei 221a trypanosomes (MITat 1.2a) of strain
S427 (36)) were grown in vitro at 37 °C in HMI-9 medium
(37). For study of MVSGs, we used the procyclic stage of
T. brucei EATRO 795 (38) maintained in vitro at
27 °C in SDM-79 medium (39). For trypanosome transformations, 5 × 107 cells were electroporated with ~5 µg of
restriction-digested, phenol/chloroform-extracted, and
ethanol-precipitated plasmid DNA. Electroporation was performed as
described previously (34). Cells were allowed to recover for 18 h
before drug selection. Bloodstream form transformants were selected on
semisolid agarose plates. Procyclic transformants (105
cells) were selected in 10 ml of liquid medium supplemented with ~106 untransformed cells. Transformant populations were
subsequently cloned using conditioned SDM-79 medium in 96-well plates.
Cloning and Sequencing T. brucei KU70 and KU80 Genes--
Using
detailed searching of the Sanger and TIGR trypanosome genome databases,
we obtained entries recognized as putative KU70 and
KU80 homologue short fragments (see "Results").
From these, we designed the following oligonucleotides:
KU705' CCGAATTCGGGGAGGGTACGTCAGCGGG; KU703' CCAAGCTTCAAGCTCTCGATTTGGATAGC;
KU805' GAATTCTTCCTCTGCGTGCCGTTGAC; KU803'
GAATTCGCACCTCTTCACCTACCGTC (EcoRI
underlined, HindIII in bold). PCR was carried out with ~3
pmol of each primer with an initial 10-min denaturation at 95 °C
followed by 30 cycles of 95 °C for 1 min, 65 °C for 1 min, and
72 °C for 1 min. Products of 248 bp (KU70) and 214 bp
(KU80) were cloned into pBluescript (Stratagene). The
sequence was determined on both strands using ABI-PRISM automated
sequencing with custom-designed primers. An insert sequence was
subsequently used to probe a T. brucei ILTat 1.2 genomic
library (Sau3A partial digests in
-GEM-12; gift of Nils
Burman). This initially allowed the isolation of two DNA fragments for
each gene believed to contain putative KU70 and KU80 sequence. Once again, these clones were sequenced on
both strands by ABI-PRISM automated sequencing, yielding the open
reading frames (ORFs) described under "Results."
Generation and Analysis of T. brucei KU70 and KU80
Knockouts--
Two constructs were used to delete each gene, using two
rounds of transformation. Each construct contained ~400 bp of
targeting sequence derived from sequences immediately upstream and
downstream of either ORF, meaning that transformants delete the entire
ORF. Targeting flanks for each gene were amplified by PCR using
genomic DNA and Pfu DNA polymerase (Stratagene).
KU70 5' flank primers: 5'-CCTCTAGAGAGGCGCTTCTCAATCTAAT-3';
5'-CCTCTAGATATCACGCGGTACCCAGGTT-3'. KU70 3' flank
primers: 5'-CCTTGGGCCCAACCATTGCGAGTGCGCGTT-3';
5'-CCTTGGGCCCAGAACTCGAGCCTTGCAGTGGGATTCTCTA-3'. KU80 5' flank primers:
5'-CCTCTAGACAGCCAGCAGCGCTTCAATA-3';
5'-CCTCTAGAACGGAAAGCCATATTGGAG-3'. KU80 3' flank
primers: 5'-CCTTGGGCCCGAGAAACAAAGTCACATATAAATA-3'; 5'-CCTTGGGCCCAGAACTCGAGTGAGATGTGGCGAACAGAGGAGTA-3'
(ApaI underlined, XhoI in bold, and
XbaI italicized). Each 5' flank product was digested with
XbaI and cloned independently into both pTBT and pTPT (gifts
of M. Cross and P. Borst, the Netherlands Cancer Institute). pTBT
contains the 400-bp blasticidin S deaminase ORF (BSR)
flanked by 240 bp of 5' and 330 bp of 3' processing signals derived
from the 5' and 3' flanks of T. brucei
-tubulin ORF. pTPT
contains identical processing signals flanking the 600-bp puromycin
N-acetyltransferase (PAC) ORF . Amplified 3'-targeting flanks for each gene were independently digested with ApaI
and cloned into both pTBT and pTPT already containing the respective 5'-targeting flank. The final transformation constructs were digested with NotI and XhoI prior to being transformed
into T. brucei, and transformants were selected with 10 µg·ml
1 blasticidin or 1 µg·ml
1 puromycin.
Correct integration of cassettes into both KU loci was
determined by Southern blot analysis. Genomic DNA from KU
wild type and mutant cell lines was digested with EcoRI and
separated on a 0.6% agarose gel. The gel was subsequently
Southern-blotted onto Hybond XL (Amersham Biosciences) and
probed with the same KU70 and KU80 ORF-derived
sequences used to probe the genomic library. Following hybridization,
the blots were washed to a final stringency of 0.2× SSC, 0.1% SDS at
65 °C. A 12-kb fragment corresponding to intact KU70 was
detected in both wild type and heterozygous cell lanes but was absent
in the homozygous mutants. Two bands were present in KU80
wild type lanes due to allelic differences (~9 and 15 kb). One of
these bands was lost upon disruption of the first allele, whereas both
were lost in ku80 homozygous mutants. Probing the blots with
KU70 and KU80 5'-flanking sequence confirmed the
correct integration of the BSR and PAC resistance
cassettes. Again, the blots were washed to a final stringency of 0.2×
SSC, 0.1% SDS.
Re-expressing KU70 in the Homozygous Knockouts--
Construct
pCC101 was used to reintroduce KU70 to its original locus.
The entire KU70 ORF, along with 620 bp of 5'-flanking sequence, was isolated as a 2.9-kb PCR-amplified fragment using the
following primers: KU70RE-EXPFOR,
5'-GGCCAAGTTAACGCTTCAGCTGATGGTCGCC-3', KU70RE-EXPREV;
5'-GGATCGGTTAACGCGCAACCGAGGAGGAAACC-3'
(ApaI underlined). The fragment was amplified using a
10-min denaturation step followed by 30 cycles of 1 min at 95 °C, 1 min at 55 °C, and 6 min at 72 °C. This was followed by 10 min at
72 °C. This reaction was carried out using Pfu DNA
polymerase, and the fragment was cloned into a unique HpaI
restriction enzyme site in pNR101. This placed the KU70
sequence upstream of a construct with ~400 bp of actin intergenic sequence at the 5' flank of the bleomycin resistance gene and 330 bp of
an
-
-tubulin intergenic region at the 3'end. In the homozygous
mutants, the 620 bp of KU70 5' flank and
-
intergenic region act as targeting flanks, allowing KU70 to be
reintroduced into the disrupted locus. The only potential difference in
expression is that 3' processing is provided by the actin intergenic
region rather than the natural KU70 3' signals. The pCC101
was linearized with NotI prior to electroporation, and
transformants were selected on semisolid agarose plates containing 2.0 µg·ml
1 bleomycin (Invitrogen). Integration of
re-expression cassettes was tested by Southern blot analysis; genomic
DNA was digested with EcoRI, separated on a 0.6% agarose
gel, Southern-blotted, and probed with the KU70 ORF
sequence. Each transformant had integrated the KU70
re-expression cassette, as expected. The control construct used in this
analysis (pRM450) contains the bleomycin-resistant gene
(BLE) surrounded by the same processing signals as in
pTBT/pTPT and targets the tubulin array. This was cut with
NotI and XhoI for transformation and targets the
tubulin locus.
Generation and Analysis of Trypanosome VSG Switchers--
The
method used to measure frequencies at which the various cell lines
switch their VSG coat has been described previously (34). Mice
immunized against the VSG221 coat were injected with 5 × 107 trypanosomes of the clones 3174.2 wild type (wt),
70Pac3.1+/
, 70Pac4.2+/
, 70Pac3.1B
/
, or 70Pac4.2B
/
. The mice
were sacrificed by cardiac puncture 24 h later, and trypanosomes
were isolated and cloned in 96-well plates as described previously
(40). The number of switched clones that grew through was used to
calculate the frequency of switching events and assumed an in
vivo doubling time of 8 h.
Viability and Growth of ku70 Mutants in the Presence of DNA
Damaging Agents--
To test the ability of ku70 mutants to
grow and divide in the presence of the DNA damaging agents
methyl methanesulfonate (MMS; Sigma) or phleomycin (Cayla), a
subclonal viability assay was adopted. Cell lines were grown to a
maximum density of 2 × 106 cells·ml
1
but more typically from 5 × 105 to 1 × 106 cells·ml
1. Each cell line was then
diluted to a concentration of 25 cells·ml
1 in HMI-9
with or without MMS or 50 cells·ml
1 for phleomycin.
Each mutagen was titrated against wild type trypanosomes to determine
the sublethal range. To assess the effect of MMS on growth, the diluted
cells were spread over a 96-well culture dish (5 cells/well for MMS, 2 cells/well for phleomycin, minimum densities giving reproducible growth
data), and the number of wells with growing trypanosome populations
were counted after 7-9 days. In vitro growth rates were
measured by diluting mid-log bloodstream trypanosomes to a
concentration of 1 × 105·ml
1 in 1.5 ml of HMI-9 medium in 24-well culture dishes. Cell concentrations were
measured using a hemocytometer (Sigma).
Telomere Length Maintenance Assay--
Wild type, heterozygotic,
and homozygotic KU70 and KU80 cell lines were
subcloned on semisolid agarose HMI-9 plates. Multiple clones for each
were then grown to a density of 2 × 106
trypanosomes·ml
1, and genomic DNA was prepared and
digested with EcoRI or AgeI depending on the
expression site under analysis. EcoRI cuts 3 kb upstream of
VSG221, which is located in the active expression site.
AgeI cuts just within the 5' end of the coding sequence of
the VO2 gene in the transcriptionally inactive expression
site analyzed. Genomic DNA digests were separated on a 0.6% agarose gel, Southern-blotted onto Hybond XL (Amersham Biosciences), and probed with the amino terminus region of either VO2 or
VSG221.
Analysis of Transcriptional Status of Metacyclic VSGs--
Three
previously characterized metacyclic VSG loci were used to
analyze the transcriptional status of MVSGs in the procyclic stage. Total RNA from KU70 wild type, heterozygous, and
homozygous mutant cell lines was prepared using TRIzol. cDNA was
generated using random hexamers and Superscript II reverse
transcriptase (following protocols from Invitrogen). Integrity of
cDNA was tested using a control PCR on cDNA to amplify RNA
polymerase I mRNA as described previously (41). Three characterized
MVSG loci, MVSG1.22, 1.61, and
1.63, were examined by PCR for the presence of transcripts both proximal to the promoter and around the VSG. PCR was
carried out on the cDNAs with ~3 pmol of upstream and downstream
primers with an initial 10-min denaturation at 95 °C followed by 30 cycles of 95 °C for 1 min, 55 °C for 1 min, and 72 °C for 1 min. These reactions were carried out using TaqDNA
polymerase (Abgene Ltd.) for each locus except the MVSG1.61
promoter proximal region, where Pfu DNA polymerase was used
with 2 mM MgSO4 and a lower annealing temperature of 50 °C. The PCR primers were designed as follows: MVSG1.22 promoter proximal, primer 5' ends were +29 and +214
from the transcription start site defined from metacyclic
nascent transcripts,2 and
VSG coding sequence primer 5' ends were +426 and +666 from the ATG start codon, which is 2934 bp from the transcription start; MVSG1.61 proximal promoter ends were +28 and +287 from
transcription start, and coding sequence ends were
5 and +305 from
ATG, which is 2783 bp from the transcription start; MVSG1.63
proximal promoter ends were +59 and +230 from transcription start, and
coding sequence ends were +621 and +837 from ATG, which is 2988 bp from
the transcription start.
 |
RESULTS |
Trypanosome Ku Homologues Are Not Colinear--
As neither Ku70
nor Ku80 has a high degree of interspecies similarity even at the
polypeptide level (42), the T. brucei genome sequence
databases were blast-searched individually with all known homologues.
Although most hits were unique to each query sequence, some were shared
by more than one. Detailed searching of databases, using Smith-Waterman
algorithms, supported the view that these common hits did indeed
correspond to Ku homologues. Using PCR-amplified fragments based on
these sequences as probes, full-length trypanosome sequences were
obtained by the isolation of overlapping genomic clones from our
existing genomic library. Sequence analysis revealed complete open
reading frames (trypanosomes are almost fully intronless)
potentially encoding polypeptides of 81 kDa for the Ku70 homologue and
69 kDa for the Ku80 homologue. It was possible to align parts of those
sequences with the primary homology regions (PHRs) of other Ku
homologues by Clustal W analysis (Fig.
1). The predicted sizes of the
trypanosome Ku proteins are the inverse of what occurs in other
organisms, and their designation is complicated further by the general
relatedness of Ku70 and Ku80 and the dispersion of homologous sequences
throughout the proteins. Our belief that the larger protein corresponds
to Ku70 relies on the outcome of blastp and PSI-blast searching, which routinely place it closer to Ku70 than Ku80 proteins, and the presence
at its carboxyl-terminal of a partial putative DNA binding SAP domain
(6, 43) that has the secondary structure potential of other SAP
sequences. Trypanosome Ku80 likewise detects mainly Ku80 sequences in
blast searching. It does not have a recognizable DNA-dependent protein kinase binding sequence found at the
end of vertebrate Ku80 proteins, but neither do the yeast Ku80
proteins.

View larger version (120K):
[in this window]
[in a new window]
|
Fig. 1.
Alignment of the amino acid sequences of
eukaryotic Ku proteins. Amino acid residues are shown in single
letter code, and the predicted T. brucei polypeptides are
compared with Ku70 and Ku80 polypeptide sequences from Homo
sapiens, Xenopus laevis, Rhipicephalus
appendiculatus, Arabidopsis thaliana, Drosophila
melanogaster, S. pombe, and S. cerevisiae.
Residues that are identical for either set of polypeptides are shown in
a black background with conserved residues
represented in a gray background. These alignments depict
only the predicted PHRs as defined by Gell and Jackson (42); PHR1 to 5 are residues 49-61, 94-128, 444-518, 539-551, and 584-611,
respectively, for T. brucei Ku70, and 6-18, 18-53,
327-399, 408-420, and 462-489 for T. brucei Ku80.
|
|
Homology-based modeling using JPRED (jura.ebi.ac.uk:8888/)
reinforced the similarity of the trypanosome sequences to known Ku proteins of other organisms and also suggested a likely reason for
most of the extra length of the trypanosome Ku70. Essentially all
helices and
strands in the crystal structure of the human protein
(44) are present in the predicted trypanosome Ku70 structure, except in
the region of the ring that encircles DNA. Although in other
species there are about 50 residues between the
G and
M
strands, the trypanosome has about 120 amino acids. It is intriguing that trypanosome Ku80 has a typical 75 residues in the corresponding region, revealing an asymmetry between the two monomers in the ring region.
Null Mutants Have Normal Growth--
To analyze the function of
Ku, initially looking for general phenotypes described previously in
other organisms and then questioning possible specific roles in
VSG switching, we adopted the approach of deleting both
alleles of either KU to generate null mutants. Genomic
Southern analysis revealed that both KU70 and
KU80 probably are single copy genes (data not
shown), an interpretation subsequently confirmed during gene knockouts.
Initially, we deleted genes in bloodstream stages of T. brucei S427 grown in vitro. In the 3174.2 strain, which
is marked with the HYG and NEO antibiotic
resistance genes in its transcriptionally active telomere, we deleted
the first KU70 copy using the puromycin resistance cassette
(PAC), obtaining the independent clones, 70P3.1(+/
) and
70P4.2(+/
). Both then had the second allele deleted with the
blasticidin resistance cassette (BSR), generating the clones
70P3.1B(
/
) and 70P4.2B(
/
). A number of subclones of each of
these were derived, enabling the study of events in individual
sublineages. A similar approach was used for KU80, except
that blasticidin resistance was used first, followed by puromycin. This
generated the independent heterozygotic clones 80B1.1(+/
) and
80B1.3(+/
), from which were derived the homozygous mutant clones
80B1.1P(
/
) and 80B1.3P(
/
), respectively.
The first phenotype examined was growth. The population doubling time
of wild type 3174 trypanosomes (9.35 and 9.75 h in two experiments) compared well with those of the heterozygous mutants 70P3.1(+/
) (10.25 h), 70P4.2(+/
) (10.25 h), 80B1.1(+/
) (10 h),
and 80B1.3(+/
) (9.12 h), as well as those of the null mutants 70P3.1B(
/
) (9.75 h), 70P4.2B(
/
) (10 h), 80B1.1P(
/
) (9 h), and 80B1.3P(
/
) (9.25 h). Ku therefore is not essential for
bloodstream trypanosome growth, and its absence causes no detectable
increase in population doubling time, indicating that there is neither a general delay in the cell cycle nor chronical death of some of
the population.
Ku Is Essential for Maintenance of a Transcriptionally Active
Telomere--
Telomere length maintenance depends on Ku. In
T. brucei, it is possible to monitor the length of
individual telomeres because of the subtelomeric location of individual
VSG genes. By digesting DNA with a restriction enzyme with
a site upstream, but not downstream, of a VSG and then
probing for that gene, a fragment containing the entire telomere tract
can be detected. We have studied two distinct VSGs. The
221 gene is in the transcriptionally active telomere in the
bloodstream trypanosomes under study. The VO2 gene has one
copy in a silent telomere and a second copy that, being within a
chromosome, is flanked on both sides by restriction sites. For
KU70, the clones 70P3.1(+/
) and 70P4.2(+/
), as well as a
number of subclones of 70P3.1B(
/
) and 70P4.2B(
/
), were examined. Similarly, for KU80, we studied the clones
80B1.1(+/
) and 80B1.3(+/
) and the homozygous deletion clones
80B1.1P(
/
) and 80B1.3P(
/
).
We initially looked at the effect the absence of Ku had on the telomere
immediately downstream of the transcriptionally active expression site,
221 (Fig.
2A). Subclones were
derived for each independent homozygous and heterozygous KU
mutant. One subclone from each independent KU80 mutant was
used (Fig. 2C), whereas a more extensive analysis was
carried out for KU70 (Fig. 2B). In this, five
subclones were derived from each independent homozygous mutant and the
progenitor wild type cell line, and a total of five heterozygous
subclones were also analyzed. Terminal restriction fragment sizes were
measured by digestion with EcoRI and Southern blot analysis.
For homozygous mutants, these were generally smaller than those seen
for heterozygous or wild type cell lines (Fig. 2), indicating an
impairment of telomere maintenance or an increase in telomere
degradation.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 2.
Telomere length maintenance in KU
mutants. A, a map of the end of the active
expression site with the telomere tract represented by a series of
arrows, and an EcoRI restriction enzyme site
upstream of VSG221 gene (gray box) and the DNA
sequence encoding the amino-terminal region of VSG221 used
as a probe. The 70-bp repeats are represented by a black
box. B, genomic DNA for 20 subclones from
wt, heterozygotic (+/ ), and homozygotic ( / )
KU70 mutants digested with EcoRI,
Southern-blotted, and probed with VSG221 sequence.
Lanes 1-5, 3174.2 wt subclones 1-5; lanes 6-8,
70Pac4.2+/ subclones 1, 2, and 3; lanes 9 and
10, 70Pac3.1+/ subclones 1 and 2; lanes 11-15,
70Pac4.2B / subclones 1-5; lanes 16-20, 70Pac3.1B /
subclones 1-5. C, genomic DNA from wt KU80
heterozygotes (80B1.1+/ , 80B1.3+/ ) and homozygotic mutants
(80B1.1P / , 80B1.3P / ) digested with EcoRI,
Southern-blotted, and probed for VSG221.
|
|
To quantify the extent of telomere loss in KU mutants, and
to be certain that this phenotype was due to the loss of Ku, we reintroduced wild type Ku into its own locus using a co-transcribed bleomycin (BLE) resistance cassette (pCC101) and, as a control, we
targeted BLE to the tubulin locus (pRM450). Four null mutant subclones
(70P3.1B
/
5, 70P3.1B
/
4, 70P4.2B
/
3, 70P4.2B
/
5; Fig.
2B, lanes 20, 19, 13, and
15) were chosen for this experiment. Analysis of the active
expression site (once again using EcoRI to release terminal
restriction fragments) showed that in each case, re-expressors harbored
longer telomere tracts than did the null mutants (Fig.
3). These were grown for an estimated 18 generations during selection for transformants and then 12 more
generations in the absence of phleomycin, at which time they were
analyzed for telomere tract length. Taking the fragment sizes for all
these KU70 experiments, the transcriptionally active
221-telomere fragment was a mean 7.2 kb long (range 3-10 kb) in
homozygous mutant trypanosomes and 10.3 kb long (range 9-15 kb) in the
re-expressor trypanosomes. This fragment contains about 3 kb of
non-telomere tract sequence.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 3.
Re-expression of KU70 in
homozygous mutants increases telomere length in the active
VSG221 expression site. Trypanosome homozygous
mutant clones transformed with construct pCC101 and re-expressing Ku70
are indicated by / /+, whereas controls transformed with the
construct pRM450 are depicted by / . Genomic DNA was digested with
EcoRI, separated by gel electrophoresis, Southern-blotted,
and probed for VSG221. Molecular size markers are indicated
to the left.
|
|
A Transcriptionally Inactive Telomere Is Less Prone to Length
Changes in Ku Null Mutants--
We next looked at the effect
disrupting Ku had on a transcriptionally inactive telomere (Fig.
4). This was carried out using restriction digestion with AgeI and Southern blot analysis.
In this instance, three of the four subclones used in the
221 experiment were analyzed. The VO2 gene has
one copy in a silent telomere and a second copy that, being within a
chromosome, is flanked on both sides by restriction sites. Fragment
sizes for the telomere downstream of VO2, measured on the
same DNA samples and therefore identical lineages as for the
221 analysis, are 9.4 kb (9.1-10 kb) in homozygous mutants
and 9.8 kb (9.5-10.5 kb) in re-expressors. The telomere immediately
downstream of the VO2 gene has not been characterized, so we
cannot say how much non-telomere sequence is present in the
AgeI terminal restriction fragments.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 4.
Telomere length maintenance of an inactive
expression site in Ku70 re-expressors. KU70 homozygous
mutant clones re-expressing Ku70 are indicated by / /+, whereas
clones depicted by / were transformed with the control plasmid
pRM450. Schematics to the right of the
panel depict the VO2 VSG loci under
investigation. The upper schematic shows the telomeric
VO2 expression site with telomere repeats depicted as
arrows, VSGVO2 gene depicted as a gray
box, and 70-bp repeats depicted as a black box. An
AgeI restriction site present upstream of the telomeric
VO2 gene is shown, and the probe used for hybridization is
depicted. The lower schematic shows the chromosomal internal
VO2 gene and national flanking AgeI sites.
Genomic DNA from each transformed KU70 subclone was digested
with AgeI, Southern-blotted, and probed for
VSGVO2. Molecular size markers are indicated to the
left of the panel.
|
|
Ku Null Mutants Do Not Have a Detectable Deficiency in DNA Double
Strand Break Repair--
The third general phenotype examined was
sensitivity to MMS, which causes both single and double strand
breaks (45), and to phleomycin (bleomycin family), which causes double
strand breaks directly. The same clones as used for the initial growth
analysis were grown in the continuous presence of MMS. Standard growth curves revealed a dose-response effect on the growth of wild type trypanosomes over the range 0.0003-0.0005% MMS. The wild type 3174.2 trypanosomes displayed population doubling times of 9.35 h in the
absence of MMS, 13 h at 0.0003% MMS, 16.5 h at 0.0004%, and
28 h at 0.0005%. This compared well with those of the
heterozygous mutants where population doubling times were 9.56 h
in the absence of MMS, 12.4 h at 0.0003%, 16.6 h at
0.0004%, and 27.5 h at 0.0005%. Homozygous mutants displayed
similar population doubling times: 9.13 h in the absence of MMS,
11.75 h at 0.0003%, 15 h at 0.0004%, and 25.25 h at 0.0005%.
These results represent an average of two independently obtained data
sets. Thus, for both heterozygous and homozygous mutants of both
KU70 and KU80, the same dose-response effect
occurred, indicating no increase in mutagen sensitivity in the mutants.
Confirmation of the apparent lack of increased sensitivity in the
mutants came from a clonal growth assay in which five trypanosomes were
plated in each well of a 96-well plate and the percentage of wells
displaying growth after 96 h was scored. This test is more
sensitive but also more variable due to trypanosome founder effects.
The assay showed, again, no increased sensitivity to MMS or to
phleomycin, which we tested at two trypanosomes per well (Fig.
5).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Viability of KU70 mutants in
the presence of mutagens. 3174.2 bloodstream form trypanosomes
that had been unaltered in their KU70 gene (wt),
had one allele disrupted (KU70+/ ), or had both alleles
disrupted (ku70 / ) were plated in culture
dishes containing increasing concentrations of MMS. The same
heterozygous and homozygous mutant lines were tested also in
phleomycin, as shown in the lower panel. Surviving
populations were counted after 6-9 days and are expressed as a
percentage of the total number of wells. The data are means of four
readings (duplicate growth experiments of two independent lines).
Error bars represent standard deviations.
|
|
Ku Null Mutants Are Not Impaired in Bloodstream VSG
Switching--
Having established some of the general phenotypes
predicted for KU genes, we next asked whether there is a
specific role in the differential expression of VSG genes.
In the bloodstream stage of T. brucei S427, switching occurs
at a background rate and is achieved by a number of routes, including
transcriptional switching between telomeres and gene duplication into
telomeres. The marked strain we have used allows most of these
activation mechanisms to be detected (40), providing a convenient means
of testing for alteration in switch rate. This assay was applied to the
KU70 mutant lines 70P3.1(+/
), 70P4.2(+/
),
70P3.1B(
/
), and 70P4.2B(
/
). All gave the rate of 0.1-0.6 × 10
6 switch/cell/generation (Fig.
6), which is typical of wild type cells,
there being no evidence for a significant decrease in switch rate in
the absence of Ku70. Examination of the switching events from a
selection of the switched variants recovered indicated further that
there was no change in the relative levels of transcriptional versus recombinational VSG switching (data not
shown).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
VSG switching frequencies in
KU70 mutants. Wild type cells (3174.2 wt) were compared with two KU70 heterozygous mutants
(70P3.1+/ , 70P4.2+/ ) and two homozygous mutants (70P3.1B / ,
70P4.2B / ). Each bar in this graph represents an
independent experiment.
|
|
Ku Is Not Essential for Silencing of the Naturally Telomeric MVSG
Genes--
VSG genes are first expressed in the metacyclic
stage of the trypanosome life cycle, in the tsetse. Differential
expression of the subset of telomeric genes used there, known as
MVSG genes, occurs by transcriptional activation. In most
life cycle stages, MVSGs are not expressed, but individual
ones are activated in individual metacyclic trypanosomes. Here, we
tested the hypothesis that the silencing of MVSGs in the
procyclic (tsetse midgut) stage is exerted by a Ku-mediated telomere
position effect. We have tried repeatedly to transmit T. brucei S427 through tsetse, to no avail (data not shown), so we
have been unable to identify MVSGs in this strain.
Therefore, we instead used T. brucei EATRO 795, which
routinely develops to the metacyclic stage, permitting characterization
of the MVSGs encoding the ILTat 1.22, 1.61, and 1.63 VSGs.
We deleted both KU70 alleles in procyclic stage T. brucei EATRO 795 grown in vitro, creating the
independent heterozygous, puromycin-resistant knockout cloned lines
70+/
1 and 70+/
2 and then their homozygous, blasticidin-resistant
doubly deleted clonal descendants called, respectively, 70
/
1.1 and
70
/
2.1. RT-PCR was used to search for transcripts from two regions
of each MVSG locus. The first, downstream of the
transcription start sites (Fig. 7), would
detect primary transcripts. The second, including the amino-terminal
VSG coding sequence, would detect primary transcripts and
stable RNA. The scant availability of metacyclic stage RNA prevented
its use as a positive control, so instead of metacyclic cDNA, we
used the corresponding trypanosome genomic DNA. Although this control
(Fig. 7, A and B, lane 11) and an
RNA POLI positive control for integrity of cDNA were
both positive (Fig. 7C), no RT-PCR products were detected in
wild type, heterozygous, or homozygous mutants for any of the three
MVSG loci immediately downstream of their promoters (Fig.
7A). Similarly, nothing was detected for the coding region
(Fig. 7B).

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 7.
Transcriptional status of telomeric
MVSGs in procyclic form KU70
mutants. RT-PCR analysis was undertaken with RNA from wild
type and mutant lines. The telomeric environment of the three
MVSGs (1.22, 1.61, and 1.63) examined is depicted in the top
diagram; the promoter is shown as a black flag, the small
number of 70-bp repeats is shown as a white box, and the
VSG gene is shown as a white arrow.
Converging arrows below the expression site show the
positions of oligonucleotides used for PCR. A, PCR of the
cDNA and mock cDNA for each MVSG proximal to the
promoter. B, PCR of the three MVSG sequences.
Lanes 1 (RT+) and 2 (RT ) shown are for wild
type cDNAs, lanes 3 (RT+) and 4 (RT ) are
from 70+/ 1.1, lanes 5 (RT+) and 6 (RT ) are
from 70+/ 1.2, lanes 7 (RT+) and 8 (RT ) are
from 70 / 1.1 (6), lanes 9 and 10 are from
70 / 1.2 (1), and lane 11 is a control PCR using the
respective primers on EATRO 795 procyclic genomic DNA. C,
RT-PCR amplification of the RNA polymerase I large subunit as a control
for cDNA integrity. Lane order is identical to panels A
and B, although no genomic DNA control was undertaken.
Pol I, polymerase I.
|
|
 |
DISCUSSION |
We have cloned and characterized, by gene deletion, the
trypanosome homologues of Ku70 and Ku80. Our analysis of telomere lengths revealed the telomere shortening phenotype that occurs in other
eukaryotes, but the classical role in DNA damage repair by NHEJ was not
detected. Our hypothesis that Ku is important in VSG
recombinational or transcriptional control was not supported, revealing
at least that the Ku-mediated TPE described for S. cerevisiae is not necessary for regulation of antigenic variation.
Due to the limitation that low sequence homology between Ku proteins
from different species prevents construction of homology models based
on the human Ku structure (44), our identification of these trypanosome
sequences has relied on the five primary homology regions (42) and on
our observation that most of the determined human
helices and
strands have counterparts, with corresponding spacing, in the
trypanosome sequences. In this way, it became apparent that trypanosome
Ku70 has an extra, ~70 residues in the ring that encircles DNA,
immediately upstream of PHR3. This correlates well with the observed
gaps between PHR2 and PHR3: 250 amino acids in human Ku70 (42) as
compared with 315 residues in trypanosome Ku70. Although the human Ku80
PHR2-PHR3 gap (274 residues) is colinear with Ku70, that of trypanosome
Ku80 is considerably shorter (273 residues) than in its presumed
heterodimeric partner; perhaps trypanosome Ku70 has an extra loop
available for interaction with other proteins. In common with other
simple eukaryotes, trypanosome Ku80 lacks the carboxyl-terminal motif
of higher eukaryotes for binding to the DNA-PK catalytic subunit (42),
and we cannot find evidence for the catalytic subunit sequence
in the (incomplete) trypanosome genome database. The trypanosome Ku70
contains what might be a SAP domain, in common with Ku70 from other
species (6, 43).
Our data show that Ku is central to telomere length maintenance in
trypanosomes and reveal that, in the presence of Ku, there are marked
differences between short and long telomeres and between the
transcriptionally active and inactive telomeres examined in the
kinetics of telomere lengthening. Although quantification of the extent
of telomere loss was complicated by the large terminal restriction
fragment sizes involved, regrowth of short, more accurately sized
telomeres could be monitored following reintroduction of KU70. The EcoRI terminal fragments liberated from
the active telomeric 221 locus in null mutants were, on
average, 3.1 kb shorter than in the Ku70 re-expressors after 30 population doublings. This difference was substantially lower for the
transcriptionally inactive VO2 telomere, where
reintroduction of Ku70 caused an average increase of only 400 bp.
Transcriptionally active trypanosome telomeres have previously been
demonstrated to grow faster than inactive telomeres (46). There was
also a growth difference between particularly short (~1 kb) and much
longer (>7 kb) telomeres upon re-expression of Ku70; the short
telomeres extended by ~170 bp/population doubling, as compared with
103 bp/population doubling for the longer telomeres. Such rapid
expansion resembles the growth of newly formed trypanosome telomeres
(47). Our findings presumably reflect that telomere capping is less
pronounced in transcriptionally active, or new, telomeres. Despite the
great decrease in telomere length, no trypanosome clone analyzed
appeared to have lost all telomeric sequence, and null mutant clones
with terminal restriction fragments as short as 4 kb multiplied at the
same rate as wild type cells even after 150 generations (data not
shown). A length equilibrium was reached within such periods,
indicating that the trypanosome has at least one alternative pathway
for telomere maintenance, as has been observed in other organisms
(reviewed in Ref. 48).
The main DNA repair role for Ku is in NHEJ reactions (49, 50). We found
no difference between wild type, heterozygotic, or homozygotic
KU mutants in their sensitivity to MMS, in contrast to
rad51 mutants, which display increased MMS sensitivity in
the same range of drug concentrations (34). We see also that there is
not an increased sensitivity to phleomycin. It appears, therefore, that
if Ku plays a role in the repair of trypanosome DNA damage, it would be
masked by the greater prevalence of homologous recombination. To some
extent, this is what happens in yeast KU mutants, where no
increased MMS sensitivity is detectable in diploids, and the background
role played by Ku is seen only when the more central homologous
recombination gene RAD52 is also inactivated (9, 11, 18,
51), although there is a significant increase in sensitivity to
bleomycin in both haploid and diploid stages (52). Indeed, wild type
trypanosomes and S. cerevisiae nearly exclusively use
homologous recombination when transfected, linearized DNA is integrated
into the genome. Nevertheless, the trypanosome appears to have more
capacity for alternative repair, such as is seen in the persistent
resistance to phleomycin, and there is evidence for at least one
Rad51-independent homologous recombination pathway (34). We have been
unable to find NHEJ in wild type trypanosomes using an assay for
recircularization of electroporated, restriction-digested plasmids,3 although
chromosomal integration of linear DNA constructs with non-homologous
flanking sequence gives some success.4
It remains possible that
Ku-dependent NHEJ exists in trypanosomes but is not
observed in these transformation experiments because DNA integration
operates at only the S to M cell cycle phase, where homologous
recombination may dominate in higher eukaryotes (53). Perhaps NHEJ is
limited to the G1 phase or to non-dividing trypanosome life
cycle stages, when limited DNA replication occurs.
There has been much speculation as to why parasite contingency genes
are found at telomeres. Besides the trypanosome VSGs, which
are transcribed only from telomeric loci in the distinct metacyclic and
bloodstream populations and have a large subset of silent genes at
minichromosomal telomeres, there are examples in protozoa (25, 54), the
fungus Pneumocystis (26), and even on linear plasmids in the
bacterium Borrelia hermsii (55). These systems rely on the
existence of a wide set of silent genes (or segments) and the
expression of only one gene at a time. There is a constant pressure for
expansion of the silent information, which probably is best served by
DNA recombination, generating novel sequence combinations. Telomeres
may enhance this process as they have high recombination rates and
are able to recombine with each other promiscuously, independent of
homology elsewhere on the chromosome (56). Whether telomeric location
is directly associated also with singular contingency gene expression
is unclear. Where the switch between different genes proceeds by
promoter activation and deactivation, such as in Plasmodium
or in trypanosome transcriptional switches, TPE has been invoked (25,
27, 28). However, early hopes that bloodstream VSG
transcriptional switching was controlled by a TPE were not well
supported by further experimental analysis (57), although a modified
TPE was not ruled out. A degree of TPE of a reporter gene in T. brucei has been described (58), although the effect extended only
some of the way toward the VSG promoter, which can be more
than 45 kb from the telomere tract. A case for TPE controlling the
MVSGs was more compelling because their promoters are only
about 5 kb from the telomere tract and because the trypanosome is
committed globally to post-transcriptional control of gene expression,
raising the possibility that exploitation of TPE might have been an
easy way for the trypanosome to achieve the transcriptional control
that operates on MVSGs. Within the same type of genomic
environment, most bloodstream VSG switching occurs by the
non-reciprocal duplication of silent VSGs into the final 5 kb of chromosomes. Given this involvement of MVSG
transcriptional silencing and telomere recombination, we have asked
whether Ku is involved as a global regulator in the VSG system.
It is clear from the bloodstream switching assay, which we have used
previously to demonstrate an important role for Rad51, that the absence
of Ku has no influence on either recombinational or transcriptional
switch mechanisms. Of technical necessity, this high throughput assay
is performed with the S427 strain, which switches at background rates
and with a bias against the recombinational mechanism(s); study of more
rapidly switching trypanosomes is being developed. Although we find no
evidence for Ku function in MVSG repression in the procyclic
stage, it is not ruled out that Ku does have a necessary role in the
differential expression of MVSGs in the metacyclic stage,
when global silencing is lifted, but experiments to test that are very
difficult, involving tsetse transmissions. Taking our findings
together, we believe that Ku in trypanosomes does not have a necessary
role in the VSG system. Furthermore, the great shortening of
telomeres also did not alter VSG regulation, which would be
consistent with the telomere not playing a major regulatory role in
antigenic variation. Functionally, Ku in trypanosomes may act as in
S. pombe, where it is involved in telomere maintenance but
is not involved in TPE (11), rather than as in S. cerevisiae, where it plays both roles. Two possible reasons for Ku
not being involved in VSG regulation are that it is not
localized preferentially to telomeres, as in S. pombe, or
that the structure of the chromosome end in trypanosomes differs
qualitatively from that in other organisms, keeping Ku physically
separate from the VSG genes. There is evidence in favor of
the latter possibility. In S. cerevisiae, the
telomere is thought to fold back, creating the capped structure that
results in the TPE. In organisms with longer telomere tracts, a t-loop
is formed in which it is believed the end of the telomere tract
base-pairs within the DNA duplex further up the tract. In human cells
and the protozoan Oxytricha, t-loops are long (59, 60), but
recently it has been shown that, in T. brucei, they are
shorter, being only ~1 kb long (61). We believe a consequence of this
is that the complex of proteins associated with the chromosome end is held well away from VSGs, preventing the possibility of TPE.
It may even be that evolution of the brief t-loop in trypanosomes has
occurred as a means of divorcing telomere effects from the more
exacting requirements of the VSG system.
 |
ACKNOWLEDGEMENTS |
We are grateful to Steve Jackson and
Steve Bell (Wellcome/Cancer Research Campaign Institute, Cambridge) for
discussions about Ku and in particular for opinions on the trypanosome
sequences. We thank Piet Borst and Mike Cross (Netherlands Cancer
Institute) for the gift of plasmids.
 |
FOOTNOTES |
*
This work was supported by the Wellcome Trust and the Royal
Society.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ307890, AJ311845.
A Royal Society University Research Fellow.
§
Present address: School of Biological Sciences, University of
Manchester, 2.205 Stopford Building, Oxford Road, Manchester M13 9PT, UK.
¶
A Wellcome Trust Principal Research Fellow. To whom
correspondence should be addressed. Tel.: 0044141-330-4875; Fax:
0044141-330-5422; E-mail: j.d.barry@bio.gla.ac.uk.
Published, JBC Papers in Press, March 27, 2002, DOI 10.1074/jbc.M200550200
2
M. L. Ginger, P. A. Blundell, and J. D.
Barry, unpublished results.
3
C. Conway, J. D. Barry, and R. McCulloch,
unpublished results.
4
C. Conway, R. McCulloch, and J. D.
Barry, in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
NHEJ, non-homologous end joining;
TPE, telomere position effect;
VSG, variant
surface glycoprotein;
BES, bloodstream expression sites;
ORF, open
reading frame;
RT, reverse transcription;
MMS, methyl methanesulfonate;
PHR, primary homology regions;
wt, wild type.
 |
REFERENCES |
| 1.
|
Featherstone, C.,
and Jackson, S. P.
(1999)
Mutat. Res.
434,
3-15[Medline]
[Order article via Infotrieve]
|
| 2.
|
Shore, D.
(2001)
Curr. Opin. Genet. Dev.
11,
189-198[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Dubrana, K.,
Perrod, S.,
and Gasser, S. M.
(2001)
Curr. Opin. Cell Biol.
13,
281-289[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Downs, J. A.,
and Jackson, S. P.
(1999)
Mol. Cell. Biol.
19,
6260-6268[Abstract/Free Full Text]
|
| 5.
|
Woodard, R. L.,
Lee, K. J.,
Huang, J.,
and Dynan, W. S.
(2001)
J. Biol. Chem.
276,
15423-15433[Abstract/Free Full Text]
|
| 6.
|
Aravind, L.,
and Koonin, E. V.
(2001)
Genome Res.
11,
1365-1374[Abstract/Free Full Text]
|
| 7.
|
Doherty, A. J.,
Jackson, S. P.,
and Weller, G. R.
(2001)
FEBS Lett.
500,
186-188[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Milne, G. T.,
Jin, S. F.,
Shannon, K. B.,
and Weaver, D. T.
(1996)
Mol. Cell. Biol.
16,
4189-4198[Abstract]
|
| 9.
|
Boulton, S. J.,
and Jackson, S. P.
(1996)
EMBO J.
15,
5093-5103[Medline]
[Order article via Infotrieve]
|
| 10.
|
Porter, S. E.,
Greenwell, P. W.,
Ritchie, K. B.,
and Petes, T. D.
(1996)
Nucleic Acids Res.
24,
582-585[Abstract/Free Full Text]
|
| 11.
|
Manolis, K. G.,
Nimmo, E. R.,
Hartsuiker, E.,
Carr, A. M.,
Jeggo, P. A.,
and Allshire, R. C.
(2001)
EMBO J.
20,
210-221[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Grandin, N.,
Damon, C.,
and Charbonneau, M.
(2000)
Mol. Cell. Biol.
20,
8397-8408[Abstract/Free Full Text]
|
| 13.
|
Peterson, S. E.,
Stellwagen, A. E.,
Diede, S. J.,
Singer, M. S.,
Haimberger, Z. W.,
Johnson, C. O.,
Tzoneva, M.,
and Gottschling, D. E.
(2001)
Nat. Genet.
27,
64-67[Medline]
[Order article via Infotrieve]
|
| 14.
|
Ferreira, M. G.,
and Cooper, J. P.
(2001)
Mol. Cell
7,
55-63[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Difilippantonio, M. J.,
Zhu, J.,
Chen, H. T.,
Meffre, E.,
Nussenzweig, M. C.,
Max, E. E.,
Ried, T.,
and Nussenzweig, A.
(2000)
Nature
404,
510-514[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Baumann, P.,
and Cech, T. R.
(2000)
Mol. Biol. Cell
11,
3265-3275[Abstract/Free Full Text]
|
| 17.
|
Gottschling, D. E.,
Aparicio, O. M.,
Billington, B. L.,
and Zakian, V. A.
(1990)
Cell
63,
751-762[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Boulton, S. J.,
and Jackson, S. P.
(1998)
EMBO J.
17,
1819-1828[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Baur, J. A.,
Zou, Y.,
Shay, J. W.,
and Wright, W. E.
(2001)
Science
292,
2075-2077[Abstract/Free Full Text]
|
| 20.
|
Vega-Palas, M. A.,
Venditti, S.,
and DiMauro, E.
(1997)
Nat. Genet.
15,
232-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Moxon, E. R.,
Rainey, P. B.,
Nowak, M. A.,
and Lenski, R. E.
(1994)
Curr. Biol.
4,
24-33[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Deitsch, K. W.,
Moxon, E. R.,
and Wellems, T. E.
(1997)
Microbiol. Mol. Biol. Rev.
61,
281-294[Abstract]
|
| 23.
|
Barry, J. D.,
and McCulloch, R.
(2001)
Adv. Parasitol.
49,
1-70[Medline]
[Order article via Infotrieve]
|
| 24.
|
Rudenko, G.,
Cross, M.,
and Borst, P.
(1998)
Trends Microbiol.
6,
113-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Scherf, A.,
Figueiredo, L. M.,
and Freitas-Junior, L. H.
(2001)
Curr. Opin. Microbiol.
4,
409-414[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Stringer, J. R.,
and Keely, S. P.
(2001)
Infect. Immun.
69,
627-639[Abstract/Free Full Text]
|
| 27.
|
Horn, D.,
and Cross, G. A. M.
(1995)
Cell
83,
555-561[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Rudenko, G.,
Blundell, P. A.,
Dirksmulder, A.,
Kieft, R.,
and Borst, P.
(1995)
Cell
83,
547-553[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Barry, J. D.,
Graham, S. V.,
Fotheringham, M.,
Graham, V. S.,
Kobryn, K.,
and Wymer, B.
(1998)
Mol. Biochem. Parasitol.
91,
93-105[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Cross, G. A. M.
(1996)
Bioessays
18,
283-291[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Pays, E.,
Lips, S.,
Nolan, D.,
Vanhamme, L.,
and Perez-Morga, D.
(2001)
Mol. Biochem. Parasitol.
114,
1-16[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Vanhamme, L.,
Pays, E.,
McCulloch, R.,
and Barry, J. D.
(2001)
Trends Parasitol.
17,
338-343[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Robinson, N. P.,
Burman, N.,
Melville, S. E.,
and Barry, J. D.
(1999)
Mol. Cell. Biol.
19,
5839-5846[Abstract/Free Full Text]
|
| 34.
|
McCulloch, R.,
and Barry, J. D.
(1999)
Genes Dev.
13,
2875-2888[Abstract/Free Full Text]
|
| 35.
|
Donelson, J. E.,
Hill, K. L.,
and Elsayed, N. A.
(1998)
Mol. Biochem. Parasitol.
91,
51-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Cross, G. A. M.
(1975)
Parasitology
71,
393-417[Medline]
[Order article via Infotrieve]
|
| 37.
|
Hirumi, H.,
and Hirumi, K.
(1989)
J. Parasitol.
75,
985-989[CrossRef][Medline]
[Order& |